MedPath

Reducing Disparities in Rural HIV Prevention

Not Applicable
Completed
Conditions
HIV Infections
Sexually Transmitted Infections
Interventions
Other: Virtual clinical visits with home lab kits and mailed HIV PrEP
Registration Number
NCT05319613
Lead Sponsor
University of Colorado, Denver
Brief Summary

HIV and Sexually Transmitted Infection (STI) rates are increasing in rural areas including rural Colorado. Many rural residents find it difficult to access HIV and STI prevention services.

In this study, an online survey on HIV and STI Prevention and best practices to provide access to prevention will be administered to rural residents in three zip 3 zones in rural Colorado. In addition to the baseline survey, study participants who are interested and medically eligible may initiate PrEP services with the University of Colorado HIV Prevention Program and receive PrEP through telemedicine visits, mailed home lab kits, and mailed medication. Persistence in PrEP care, acceptability, and feasibility of telemedicine and home lab kits will be measured.

Detailed Description

HIV and Sexually Transmitted Infection (STI) rates are increasing in rural areas including rural Colorado. Many rural residents find it difficult to access HIV and STI prevention services. The goal of this study is to understand the risk for HIV and STIs, views on PrEP, and to determine if access to telemedicine visits and home lab kits increases engagement in PrEP services and persistence in care for at-risk rural populations.

An online survey on HIV and STI Prevention and best practices to provide access to prevention will be administered to rural residents in three zip 3 zones in rural Colorado, comprised of increased proportions of minority residents (Hispanic, Native American, and Black). In addition to the baseline survey, study participants who are interested and medically eligible may initiate PrEP services with the University of Colorado HIV Prevention Program and receive PrEP through telemedicine visits, mailed home lab kits, and mailed medication. Persistence in PrEP care, acceptability, and feasibility of telemedicine and home lab kits will be measured through baseline and follow-up survey questionnaires and clinical chart reviews for those engaged in PrEP care.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria
  1. Colorado rural or frontier county residents, Adults (age 18+)
  2. Access to internet, smart phone or tablet to participate in online surveys
  3. Able to complete online surveys in English or Spanish
Read More
Exclusion Criteria
  1. Residence in an urban Colorado county
  2. HIV positive status
  3. No internet, smart phone, or tablet access
  4. Unable to complete online surveys in English or Spanish
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Telemedicine Clinical CareVirtual clinical visits with home lab kits and mailed HIV PrEPRural participants who enter PrEP clinical care with University of Colorado HIV Prevention Program will receive care via telemedicine with mailed lab kits and mailed HIV PrEP.
Primary Outcome Measures
NameTimeMethod
Persistence in PrEP care12 months

The proportion of study participants persisting in PrEP care at 12 months, stratified by race, ethnicity, zip 3 region, and type of insurance coverage.

Secondary Outcome Measures
NameTimeMethod
Feasibility of postal lab kits12 months

Describe feasibility of postal lab kits, as determined by survey response and completion of quarterly lab monitoring.

Acceptability of Telemedicine visits12 months

Describe acceptability of Telemedicine visits as determined by survey response and completion of quarterly visits.

Feasibility of Telemedicine visits12 months

Describe feasibility of Telemedicine visits as determined by survey response and completion of quarterly visits.

Acceptability of postal lab kits12 months

Describe acceptability of postal lab kits, as determined by survey response and completion of quarterly lab monitoring.

Medication adherence12 months

Describe PrEP medication adherence rates at 12 months (as determined by pharmacy refill data) for rural CO PrEP users who utilize Telemedicine PrEP services and postal lab kits.

HIV seroconversion12 months

Describe rate of HIV seroconversion in cohort at 12 months.

Trial Locations

Locations (1)

University of Colorado Hospital

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath